Evaluation of Allogenic Mesenchymal Stem Cell (MSC) Injection Therapy for Refractory Graft-versus-Host Disease (GVHD) Unresponsive to Conventional Treatments | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Evaluation of Allogenic Mesenchymal Stem Cell (MSC) Injection Therapy for Refractory Graft-versus-Host Disease (GVHD) Unresponsive to Conventional Treatments	dry eye syndrome, eye disorder, graft versus host disease, immune system disorder, lacrimal apparatus disorder	Not yet recruiting	Phase 2	2026-09-03		NCT06905834

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Instituto de Investigación Biomédica de Salamanca	22
Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA	5
Spanish Clinical Research Network - SCReN	6

0 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
No products are listed yet.